Release Therapeutics Secures CHF 3.3 Million in Seed Funding
The funding follows the Company’s first preclinical results in metachromatic leukodystrophy and will be invested in studies in non-human...
top of page
- Jul 19
- 3 min
Release Tx Announces Research Collaboration with Paris Brain Institute to Treat Metachromatic Leukodystrophy (MLD) and First Preclinical Results
We are thrilled to announce our strategic collaboration with Paris Brain Institute to explore the potential of our cutting-edge cell...
93 views0 comments
- Jun 27
- 2 min
Press Release: Release Therapeutics Announces New CEO to Drive Best-in-Class CNS Innovation
Release Tx Announces New CEO, aligning with the company’s recent pivot towards treating genetic disorders of the CNS without gene therapy
69 views0 comments
- Jun 18
- 7 min
Release Therapeutics publishes cutting-edge research in Cell Press
Release Therapeutics publishes cutting-edge research in Cell Press
113 views0 comments
- Jun 15
- 6 min
Treating Genetic Disorders of the CNS without Gene Therapy (or what we’ve been up to here at Release Therapeutics)
Release Therapeutics' strategic pivot towards treating genetic disorders of the central nervous system without gene therapy.
118 views0 comments
- Jun 14
- 1 min
Meet us online at RESI Europe (18-19 June 2024)
Release Therapeutics is excited to announce our participation in the virtual partnering segment of RESI Europe, Barcelona from June...
2 views0 comments
- Jan 13
- 1 min
Meet us at the WORLDSymposium
Release Tx will join the 20th annual WORLDSymposium in San Diego. https://worldsymposia.org/
17 views0 comments
- Oct 20, 2023
- 1 min
Sustained delivery of low-dose anti-CTLA-4 by genetically engineered encapsulated cells drives tumor response and prolongs survival in a colorectal cancer model
AACR American Association for Cancer Research Orlando Florida Poster Grogg et al. 2023. iScience. Engineering a versatile and retrievable...
16 views0 comments
- Sep 15, 2023
- 1 min
MaxiVAX transitions into Release Tx
We are pleased to announce that, with the recent progress in the development of its unique platform technology, MaxiVAX is morphing into...
37 views0 comments
- May 31, 2022
- 1 min
Immortalized human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology
Molecular Therapy – Methods & Clinical Development Immortalized human myoblast cell lines for the delivery of therapeutic proteins using...
10 views0 comments
- Jan 11, 2022
- 1 min
Best Poster Awards 2022: Personalized immunotherapy with encapsulated cell technology
Best Poster Awards 2022 – ESMO conference – Our ECT technology as adjuvant to an au tologous cancer vaccine.
3 views0 comments
- Jan 11, 2017
- 1 min
CTI Swiss Medtech Awards
Our ECT technology as adjuvant to an autologous cancer vaccine.
2 views0 comments
bottom of page